Skip to content

Neurology Bulletin

ISSN 1027-4898

5 papers in the library · publishing 2022-2026

Papers

Sort Most recent Most cited

Multimodal imagery and the “voice” of interpersonal trauma: dissociative-cognitive mechanisms in the dynamics of hallucinations and suicide risk

Neurology Bulletin May 20, 2026 Olga A. Sagalakova, Dmitry V. Truevtsev

BACKGROUND: Despite the established link between interpersonal violence and hallucinatory experiences, the psychological mechanisms that transform traumatic memory into perceptual disturbances remain understudied. Empirical models explaining the transition from intrusions to multimodal hallucinations and their association with suicide risk outside the psychotic spectrum are lacking. AIM: To...

New psychoactive substances (designer drugs): an approach to classification

Neurology Bulletin March 23, 2026 Azat R. Asadullin, Elvina A. Akhmetova, Ilia S. Efremov et al.

BACKGROUND: Substance use disorders remain a global public health problem. In recent decades, the drug market has undergone substantial changes, with traditional drugs increasingly replaced by new psychoactive substances characterized by high toxicity and strong addictive potential. Their distribution via the Internet and social media impedes control and increases risks to public health. AIM:...

Borderline personality disorder: identification, comorbidity, and emerging treatment opportunities

Neurology Bulletin June 14, 2025 Мikhail L. Zobin

This article analyses the diagnostic criteria for borderline personality disorder as defined in the 5th edition of Diagnostic and Statistical Manual of Mental Disorders and the 11th revision of International Classification of Diseases. The combination of categorical and dimensional diagnostic models improves its validity, which meets the needs of clinical practice. At the same time, the...

The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”?

Neurology Bulletin March 15, 2025 V. Skryabin

In recent years, there has been a significant surge of interest in psychedelic research. These studies encompass both neuroscience and their potential clinical applications. This phenomenon, often referred to as the "Psychedelic Renaissance", includes studies on compounds such as psilocybin, MDMA, DMT, and LSD used for the treatment of depression, post-traumatic stress disorder, anxiety, and...

Systematic use of LSD, mephedron and amanita muscaria without signs mental and addictive pathology. The case of Daria D.

Neurology Bulletin December 24, 2022 Vladimir D. Mendelevich, Veronika N. Konovalova, Galya M. Galiullina et al.

The article describes the case of Daria D., 23 years old, who has been using various drugs (LSD, marijuana, mephedrone) for a number of years and independently abandoned using drags with the transition to the use of microdoses of red fly agaric (Amanita Muskaria). Her mental and addictive status is analyzed. It is concluded that, despite the systematic use of drugs, there are no grounds for...